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Table2. Comparison of demographic factors, clinical features, and medications between lithium 
responders and non-responders 
 Alda≥7 (n=26) 
Mean (SD) 
Alda<7(n=70) 
Mean (SD) 
P  
Gender (M/F) 13/13 42/28 0.379 
Age 52.54 (13.19) 53.26 (10.45) 0.993 
Education duration (years) 13.58 (2.45) 13.44 (2.11) 0.876 
JART-estimated premorbid IQ 99.85 (11.91) 101.76 (10.17) 0.501 
Age at onset 35.23 (14.53) 33.79 (12.20) 0.837 
Familial history (+/−) 13/13 32/38 0.708 
HAM-D 0.81 (1.36) 2.97 (3.36) <0.001 
YMRS 1.15 (1.95) 1.20 (2.57) 0.977 
PANSS-P 7.62 (1.17) 8.30 (2.21) 0.222 
PANSS-N 8.04 (1.48) 11.37 (4.90) <0.001 
Number of mood episodes 7.27 (4.13) 11.34 (7.33) 0.012 
Psychotic features (+/−) 10/16 30/40 0.698 
Lithium (+/−) 23/0 62/7 0.186 
Valproic acid (+/−) 7/19 16/54 0.678 
Carbamazepine (+/−) 3/23 8/62 0.619 
FGA (+/−) 3/23 18/52 0.135 
SGA (+/−) 5/21 37/33 0.003 
Alda scale 7.58 (0.76) 3.36 (1.87) <0.0001 
 
Alda scale, The Retrospective Criteria of Long-Term Treatment Response in Research Subjects with 
Bipolar Disorder scale; BACS, Brief Assessment of Cognition in Schizophrenia; FGA, first-
generation antipsychotic ; HAM-D, Hamilton Rating Scale for Depression ; JART, Japanese Adult 
Reading Test; PANSS-P, Positive symptoms assessed by Positive and Negative Syndrome Scale; 
PANSS-N, Negative symptoms assessed by Positive and Negative Syndrome Scale; SFS, Social 
Functional Scale; SGA, second-generation antipsychotic ; YMRS , Young mania rating scale.  *P 
values for the differences in the demographic/clinical variables and BACS performances (z-scores of 
subdomains and composite score) between the lithium responders and non-responders were 
determined by the chi-square, Mann–Whitney U or Student t tests as appropriate.  
 
 
